Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems

Journal of Negative Results in BioMedicine

Volumn 4, Issue , 2005, Pages

  Laitala Leinonen, Tiina ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOVIRUS VECTOR; CD34 ANTIGEN; COLONY STIMULATING FACTOR 1; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOSOME; OSTEOCLAST DIFFERENTIATION FACTOR; DNA;

APOPTOSIS; ARTICLE; BONE MARROW; CELL DEATH; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DNA TRANSFECTION; ENDOSOME; GENE TARGETING; GENE TRANSFER; GENETIC SCREENING; HUMAN; HUMAN CELL; MONONUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; STEM CELL; CELL CULTURE; CYTOLOGY; GENETIC TRANSFECTION; IMMUNOLOGY; METABOLISM; METHODOLOGY; TRANSGENE;

ANTIGENS, CD34; APOPTOSIS; BONE RESORPTION; CELLS, CULTURED; DNA; HUMANS; LIPOSOMES; OSTEOCLASTS; TRANSFECTION; TRANSGENES;

EID: 24944562785     PISSN: 14775751     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-5751-4-5     Document Type: Article

References (25)

1. Väänänen HK, Zhao H, Mulari M, Halleen JM: The cell biology of osteoclast function. J Cell Sci 2000, 113:377-381.
2. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocr Rev 1992, 13:66-80.
3. Blair HC, Athanasou NA: Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 2004, 19:189-199.
4. Athanasou NA, Quinn J: Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 1990, 43:997-1003.
5. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
6. Zhang G, Budker VG, Ludtke JJ, Wolff JA: Naked DNA gene transfer in mammalian cells. Methods Mol Biol 2004, 245:251-264.
7. Banerjee R, Mahidhar YV, Chaudhuri A, Gopal V, Rao NM: Design, synthesis and transfection biology of novel cationic glycolipids for use in liposomal gene delivery. J Med Chem 2001, 44:4176-4185.
8. Ruoponen M, Honkakoski P, Tammi M, Urtti A: Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J Gene Med 2004, 6:405-414.
9. Xu Y, Szoka FC Jr: Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochem 1996, 35:5616-5623.
10. Sokoloff AV, Wong SC, Ludtke JJ, Sebestyen MG, Subbotin VM, Zhang G, Budker T, Bachhuber M, Sumita Y, Wolff JA: A new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivo. Mol Ther 2003, 8:867-782.
11. Lechardeur D, Lukacs GL: Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2002, 2:183-194.
12. Lukacs GL, Haggie P, Seksek O, Lechardeur D, Freedman N, Verkman AS: Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 2000, 275:1625-1629.
13. Ludtke JJ, Zhang G, Sebestyen MG, Wolff JA: A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci 1999, 112:2033-2041.
14. Aronsohn AI, Hughes JA: Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. J Drug Target 1998, 5:163-169.
15. Tanaka S, Takahashi T, Takayanagi H, Miyazaki T, Oda H, Nakamura K, Hirai H, Kurokawa T: Modulation of osteclast function by adenovirus vector-induced epidermal growth factor receptor. J Bone Miner Res 1998, 13:1714-1720.
16. Nesbitt SA, Helfrich M, Horton M: Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1 and alpha v beta 1 integrins. J Biol Chem 1993, 268:16737-16745.
17. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ: Hydrogen Peroxide Is Essential for Estrogen-Deficiency Bone Loss and Osteoclast Formation. Endocrinology 2005, 146:728-735.
18. Lakkakorpi P, Tuukkanen J, Hentunen T, Järvelin K, Väänänen K: Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res 1989, 4:817-825.
19. Minkin C: Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982, 34:285-290.
20. Vääräniemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SA, Andersson G, Kaija H, Vihko P, Väänänen HK: Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 2004, 19:1432-1440.
21. Prince CW: Roles of hyaluronan in bone resorption. BMC Muskuloskeletal Disorders 2004, 5:12.
22. Laitala T, Väänänen HK: Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H+-ATPase. J Clin Invest 1994, 93:2311-2318.
23. Laitala-Leinonen T, Löwik C, Papapoulos S, Väänänen HK: Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. J Cell Sci 1999, 112:3657-3666.
24. Zhao H, Parikka V, Laitala-Leinonen T., Väänänen HK: Impaired osteoclast polarization and inhibition of bone resorption induced by oligodeoxynucleotide targeted to small GTPase Rab 7. J Biol Chem 2001, 276(42):39295-302.
25. Salo J: Bone resorbing osteoclasts reveal two basal plasma membrane domains and transcytosis of degraded matrix material. PhD thesis 2002 [http://herkules.oulu.fi/isbn9514268296/]. University of Oulu, Department of Anatomy and Cell Biology